In this study, we find the differential expression of CBX5 in metastatic versus non-metastatic breast cancer cells requires a decoupling from the bi-directional promoter architecture of CBX5 and hnRNPA1, and investigate sequences downstream of the CBX5 promoter as possible mediators hereof. The gene discussed is CBX5; the disease is breast cancer.